BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months

Biotech catalysts in 2026-01

182 industry Phase 2/3 trial readout(s) and 20 FDA decision event(s). Readouts include completed (ACTUAL) and still-estimated primary completion dates in this month, any status.

← 2025-12 | 2026-02 →

FDA decision events

DateEventStatusCompanyDrugSource
2026-01-09Complete response lettercomplete responsePierre Fabre Pharmaceuticals Inc.tabelecleucel®CRL 2026-01-09: Pierre Fabre Pharmaceuticals Inc. BL 125745 (tabelecleucel® (4), (1)
2026-01-12FDA approvalapprovedGENZYMECEREZYMEApproved 2026-01-12: CEREZYME (BLA020367 SUPPL123)
2026-01-12FDA approvalapprovedSENTYNL THERAPS INCZYCUBOApproved 2026-01-12: ZYCUBO (NDA211241 ORIG1)
2026-01-15FDA approvalapprovedACCORD BIOPHARMA INC.FILKRIApproved 2026-01-15: FILKRI (BLA761027 ORIG1)
2026-01-16FDA approvalapprovedORGANON OGNIMPLANON NEXPLANONApproved 2026-01-16: IMPLANON; NEXPLANON (NDA021529 SUPPL27)
2026-01-21FDA approvalapprovedMSDVERQUVOApproved 2026-01-21: VERQUVO (NDA214377 SUPPL5)
2026-01-21FDA approvalapprovedCELLTRION INCAVTOZMAApproved 2026-01-21: AVTOZMA (BLA761498 ORIG1)
2026-01-23FDA approvalapprovedAPOTEXCALDOLORApproved 2026-01-23: CALDOLOR (NDA022348 SUPPL28)
2026-01-23FDA approvalapprovedMANNKIND MNKDAFREZZAApproved 2026-01-23: AFREZZA (BLA022472 SUPPL27)
2026-01-26FDA approvalapprovedSOLUBIOMIXQUIOFICApproved 2026-01-26: QUIOFIC (NDA216395 ORIG1)
2026-01-27FDA approvalapprovedMERCK SHARP DOHME MRKNOXAFILApproved 2026-01-27: NOXAFIL (NDA205053 SUPPL18)
2026-01-27FDA approvalapprovedGLAUKOS GKOSIDOSE TRApproved 2026-01-27: IDOSE TR (NDA218010 SUPPL4)
2026-01-27FDA approvalapprovedMERCK SHARP DOHME MRKNOXAFILApproved 2026-01-27: NOXAFIL (NDA205596 SUPPL21)
2026-01-27FDA approvalapprovedSCHERINGNOXAFILApproved 2026-01-27: NOXAFIL (NDA022003 SUPPL34)
2026-01-27FDA approvalapprovedJAZZ PHARMS THERAP JAZZVYXEOSApproved 2026-01-27: VYXEOS (NDA209401 SUPPL18)
2026-01-27FDA approvalapprovedMSD MERCK CONOXAFIL POWDERMIXApproved 2026-01-27: NOXAFIL POWDERMIX KIT (NDA214770 SUPPL9)
2026-01-27FDA approvalapprovedJANSSEN BIOTECHDARZALEX FASPROApproved 2026-01-27: DARZALEX FASPRO (BLA761145 SUPPL28)
2026-01-28Complete response lettercomplete responseCorcept Therapeutics CORTrelacorilantCRL 2026-01-28: Corcept Therapeutics NDA 219398 (relacorilant capsules)
2026-01-28FDA approvalapprovedVISUSYUVEZZIApproved 2026-01-28: YUVEZZI (NDA220142 ORIG1)
2026-01-30Complete response lettercomplete responseAquestive Therapeutics Inc. AQSTdibutepinephrine sublingual filmCRL 2026-01-30: Aquestive Therapeutics Inc. NDA 219870 (dibutepinephrine sublingual film)

Trial readouts

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2026-01 est.P3Aesculap Biologics, LLCNCT03219307 NOVOCART 3D Treatment Following Microfracture FailureArticular Cartilage Defectactive not recruiting30
2026-01 est.P3WockhardtNCT03630081 Study of Cefepime-tazobactam (FEP-TAZ) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)Complicated Urinary Tract Infection; Acute Pyelonephritisunknown1004
2026-01 est.P1/P2Immunity Pharma Ltd.NCT03652805 A Study of IPL344 in the Treatment of ALS PatientsAmyotrophic Lateral Sclerosissuspended15
2026-01 est.P1/P24D Molecular Therapeutics FDMTNCT04519749 An Open-label, Phase 1/2 Trial of Gene Therapy 4D-310 in Adults With Fabry DiseaseFabry Diseaseactive not recruiting18
2026-01 est.P1/P2Treadwell Therapeutics, IncNCT04730258 A Study of CFI-400945 With or Without Azacitidine in Patients With AML, MDS or CMMLAcute Myeloid Leukemia; Myelodysplastic Syndromes; Chronic Myelomonocytic Leukemia; AML; MDS; CMMLactive not recruiting72
2026-01 est.P1/P2Azitra Inc. AZTRNCT04731259 Study to Evaluate the Safety of ATR-04Epidermal Growth Factor; Papulopustular Rosaceawithdrawn
2026-01 est.P2ASC TherapeuticsNCT04883918 ASC930 in Patients With Steroid-Refractory Acute Graft Versus Host Disease (SR-aGVHD)Acute-graft-versus-host Diseaseunknown60
2026-01 est.P3Inmunotek S.L.NCT04891237 Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive PollenRhinitis, Allergic; Rhinoconjunctivitis; Asthma, Allergicrecruiting180
2026-01 est.P1/P2Immunitas TherapeuticsNCT05565417 Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or LymphomasNon Small Cell Lung Cancer; Head and Neck Squamous Cell Carcinoma; Triple Negative Breast Cancer; Cuactive not recruiting67
2026-01 est.P3R-Pharm International, LLCNCT05673902 Study of the Safety and Efficacy of RPH-104 in Preventing Recurrences in Patients With Idiopathic Recurrent PericarditisIdiopathic Recurrent Pericarditisactive not recruiting17
2026-01 est.P3Theravance BiopharmaNCT05696717 Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System AtrophySymptomatic Neurogenic Orthostatic Hypotension; MSA - Multiple System Atrophyactive not recruiting102
2026-01 est.P1/P2Traws Pharma, Inc. TRAWNCT05705505 Study of Narazaciclib (ON 123300) Plus Letrozole in Endometrial Cancer and Other Gynecologic MalignanciesEndometrioid Endometrial Cancerunknown60
2026-01 est.P3CSPC ZhongQi Pharmaceutical Technology Co., Ltd.NCT05901935 DP303c in Patients With HER2-positive Advanced Breast CancerHER2-positive Advanced Breast Cancernot yet recruiting420
2026-01 est.P2AnaptysBio, Inc. ANABNCT06127043 A Study of Efficacy and Safety of Rosnilimab in Subjects With Moderate to Severe Ulcerative Colitis (ROSETTA)Ulcerative Colitisactive not recruiting132
2026-01 est.P2AkesoNCT06196203 A Study of AK117 in Combination With Azacitidine in Patients With Myelodysplastic SyndromesHigher-risk Myelodysplastic Syndromesrecruiting90
2026-01 est.P1/P2Dong-A ST Co., Ltd.NCT06293651 Clinical Trial to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of DA-4505 as a Single Agent and in Combination With PembroLocally Advanced or Metastatic Solid Tumorsrecruiting125
2026-01 est.P2Fujian Shengdi Pharmaceutical Co., Ltd.NCT06391710 HRS9531 Injection in Obese Subjects With Heart Failure With Preserved Ejection FractionHeart Failure With Preserved Ejection Fractionactive not recruiting203
2026-01 est.P2Hope Biosciences Research FoundationNCT06623240 HB-adMSCs vs Placebo for the Treatment of Juvenile Idiopathic ArthritisJuvenile Idiopathic Arthritis (JIA)withdrawn
2026-01 est.P3CanSino Biologics Inc.NCT06857370 Inter-lot Consistency Clinical Trial of Adsorbed Cell-free DTP (Three-component) Combined VaccineDiphtheria, Tetanus and Acellular Pertussisactive not recruiting780
2026-01 est.P1/P2Jiangsu HengRui Medicine Co., Ltd.NCT07070349 A Trial of HRS-6213 in Healthy Subjects and Patients With Solid TumorsPatients With Solid Tumorsrecruiting48
2026-01 est.P2Guangzhou Patronus Biotech Co., Ltd.NCT07311148 A Immunogenicity and Safety Trial of the Recombinant Zoster Vaccine (CHO Cell), LYB004 in Adults Aged 40 Years and OlderHerpes Zoster (HZ); Shingles; VZV; Recombinant Zoster Vaccineactive not recruiting840
2026-01-01 est.P1/P2ENB Therapeutics, IncNCT04205227 ENB003 Plus Pembrolizumab Phase 1b/2a in Solid TumorsCancer; Melanoma; Ovary Cancer; Pancreatic Cancer; Solid Tumorunknown137
2026-01-01 est.P1/P2Rapa Therapeutics LLCNCT05144698 RAPA-201 Therapy of Solid TumorsSolid Tumor; Small Cell and Non-small Cell Lung Cancer; Head and Neck Cancer; Squamous Cell Carcinomrecruiting37
2026-01-01 est.P1/P2Ashvattha Therapeutics, Inc.NCT05395624 Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy VolunteersAmyotrophic Lateral Sclerosis (ALS); Parkinson Disease (PD); Alzheimer Disease (AD); Multiple Sclerorecruiting65
2026-01-01 est.P2HEM Pharma Inc.NCT05527301 HEM1036 Phase 2 Study in Low Anterior Resection SyndromeLARS - Low Anterior Resection Syndromeunknown67
2026-01-01 est.P3ONYNCT05960929 InfasurfAero™ Versus Sham Treatment in Preterm Newborns With RDSRespiratory Distress Syndrome (Neonatal); Intubation Complication; Death; Neonatalrecruiting220
2026-01-01 est.P1/P2Cellcolabs Clinical LTD.NCT06070532 A Study of Human Allogeneic Bone-marrow-derived Mesenchymal Stromal Cell Product (StromaForte) in Patients With Aging FrailtyFrailtynot yet recruiting12
2026-01-01 est.P2MedRegen LLCNCT06315608 MRG-001 in Patients With Amyotrophic Lateral SclerosisAmyotrophic Lateral Sclerosis; Lou Gehrig Disease; Motor Neuron Disease; Motor Neuron Atrophyunknown10
2026-01-01 est.P1/P2Suzhou Suncadia Biopharmaceuticals Co., Ltd.NCT06703177 A Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With Solid TumorsAdvanced Solid Tumorsrecruiting876
2026-01-01 est.P2Oragenics, Inc. OGENNCT06870240 A Randomised, Double-blind, Placebo-controlled Phase 2a Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ONP-002 in AdMild Traumatic Brain Injury, Concussionnot yet recruiting40
2026-01-02P2Lipomedix Pharmaceuticals Inc.NCT06478862 Promitil Treatment of Patients With Solid Tumors Associated With Deleterious Mutations Who Have Progressed After TherapyCancer of Ovary; Pancreatic Ductal Adenocarcinomaterminated19
2026-01-02P2Alume Biosciences, Inc.NCT06662097 A Study of Bevonescein in Patients Undergoing Abdominopelvic SurgerySurgery; Nerve Injury; Imagingcompleted27
2026-01-02P2Jiangsu Hansoh Pharmaceutical Co., Ltd.NCT07550387 A Study Assessing the Efficacy and Safety of HS-10380 in Hospitalized Adults With Acute SchizophreniaSCHIZOPHRENIA 1 (Disorder)completed363
2026-01-04P3Jiangsu Hansoh Pharmaceutical Co., Ltd.NCT06839664 A Study of HS-20094 in Chinese Adults With Overweight or ObesityOverweight; Obesitycompleted604
2026-01-05P2Cartesian Therapeutics RNACNCT04146051 Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG)Myasthenia Gravis, Generalizedactive not recruiting30
2026-01-05P2Agenus Inc. AGENNCT05630183 A Study of Botensilimab in Participants With Metastatic Pancreatic CancerMetastatic Pancreatic Ductal Adenocarcinomacompleted81
2026-01-05P2Teva Branded Pharmaceutical Products R&D LLCNCT05668013 A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's DiseaseCrohn Disease; Colitis, Ulcerativeactive not recruiting247
2026-01-05P3Alexion Pharmaceuticals, Inc.NCT06291376 Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)Immunoglobulin A Nephropathy; IgANactive not recruiting584
2026-01-05 est.P3AbbVie ABBVNCT06390722 A Study to Assess the Effect of Upadacitinib in Atopic Dermatitis-induced Sleep Disturbance in Adults With Moderate to Severe Atopic DermatitisAtopic Dermatitis; Sleep Disturbancewithdrawn
2026-01-06P2Amgen AMGNNCT06054113 Study of Blinatumomab Administration in Chinese Pediatric Participants With Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)B Precursor Acute Lymphoblastic Leukemia; Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemactive not recruiting18
2026-01-06P3Alexion Pharmaceuticals, Inc.NCT06079359 Phase 3 Study of ALXN1850 in Treatment-Naïve Pediatric Participants With HPPHypophosphatasiaactive not recruiting30
2026-01-06P3Chengdu Suncadia Medicine Co., Ltd.NCT06715943 Efficacy and Safety of HRS-5965 in Patients With PNH Who Are Still Anemia After Anti-C5 Antibody TreatmentParoxysmal Nocturnal Hemoglobinuriacompleted39
2026-01-07P3Delta-Fly Pharma, Inc.NCT03926624 Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th SalvageLeukemia, Myeloid, Acuteterminated167
2026-01-07P2Pharmicell Co., Ltd.NCT04594850 Clinical Trial to Evaluate Efficacy and Safety of of Autologous Mesenchymal Stem Cells (MSC) Injected IntracavernouslyErectile Dysfunctioncompleted54
2026-01-07P2AstraZeneca AZNNCT05251259 Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled AsthmaAsthmacompleted670
2026-01-07P3Pfizer PFENCT05477524 An Efficacy, Safety, Tolerability, Immunogenicity, and Lot-Consistency Clinical Trial of a 6-Valent OspA-Based Lyme Disease Vaccine (VLA15)Lyme Diseasecompleted12546
2026-01-07P2Eli Lilly and Company LLYNCT06683508 A Study to Investigate Weight Management With LY3549492 Compared With Placebo in Adult Participants With Obesity or OverweightObesity; Overweightcompleted288
2026-01-07P2Latigo Biotherapeutics LTGONCT07102459 An Efficacy and Safety Study of LTG-001 Following AbdominoplastyAcute Pain; Postoperative Pain Controlcompleted343
2026-01-07 est.P2Suzhou Abogen Biosciences Co., Ltd.NCT07289542 Phase II Clinical Trial of Lyophilized Respiratory Syncytial Virus mRNA Vaccine in Adults Aged 50 Years or AboveRespiratory Syncytial Virusactive not recruiting420
2026-01-08P2Innate Pharma IPHANCT03902184 IPH4102/Lacutamab Alone or in Combination With Chemotherapy in Patients With Advanced T Cell LymphomaLymphoma, T-Cell; Lymphoma, T-Cell, Cutaneous; Mycosis Fungoides/Sezary Syndromecompleted170
2026-01-08P2Eli Lilly and Company LLYNCT06037252 A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and ObesityType 2 Diabetes; Obesityactive not recruiting414
2026-01-08P3Hanmi Pharmaceutical Company Limited HAFCNCT06174766 A Study to Evaluate Efficacy and Safety of HGP2304 in Essential Hypertension PatientsHypertensioncompleted356
2026-01-08P3Eli Lilly and Company LLYNCT06588283 Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or OverweightPsoriasis; Obesitycompleted281
2026-01-08P2Fujian Shengdi Pharmaceutical Co., Ltd.NCT06841445 Efficacy and Safety of HRS9531 Tablet in Obese SubjectsChronic Management of Body Weightcompleted166
2026-01-08P2Halia Therapeutics, Inc.NCT07052006 A Phase 2a Study of HT-6184 in Subjects With IPSS-R Very Low, Low or Intermediate Risk MDS and AnemiaMyelodysplastic Syndrome; Anemia in Myelodysplastic Syndromescompleted37
2026-01-09P2BeiGeneNCT04116437 Zanubrutinib (BGB-3111) in Participants With Previously Treated B-Cell Lymphoma Intolerant of Prior Bruton Tyrosine Kinase Inhibitor (BTKi) TreatmentChronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma; Mantle Cell Lymphoma; Marginal Zone Lymphomcompleted96
2026-01-10P3RDC Clinical Pty LtdNCT06827327 LC-Plasma for Preventing URTIs and Reducing SymptomsHealthy Volunteer; URTIcompleted637
2026-01-12P3Chiesi Farmaceutici S.p.A.NCT04320342 A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects WithCOPD; COPD Exacerbationcompleted3406
2026-01-12P3Eli Lilly and Company LLYNCT04819100 A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC)Carcinoma, Non-Small-Cell Lungactive not recruiting152
2026-01-12P3Janssen Research & Development, LLCNCT05083182 A Study of Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic ArthritisArthritis, Juvenilecompleted48
2026-01-12P2Idorsia Pharmaceuticals Ltd.NCT05423717 Dose-finding Study Assessing the Efficacy, Safety, and Pharmacokinetics of Daridorexant in Subjects Aged 10 to < 18 Years With Insomnia DisorderInsomniacompleted166
2026-01-12P3Xenon Pharmaceuticals Inc. XENENCT05614063 A Randomized Study of XEN1101 Versus Placebo in Focal-Onset SeizuresFocal Onset Seizurescompleted380
2026-01-12P3Soleno Therapeutics, Inc.NCT05701774 Open-Label Extension Study of DCCR in Patients With Prader-Willi SyndromePrader-Willi Syndromecompleted77
2026-01-12P2Genentech, Inc.NCT05785624 A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-AssociaIdiopathic Pulmonary Fibrosis; Systemic Sclerosis With Lung Involvementterminated286
2026-01-12P2AstraZeneca AZNNCT05925530 Study to Assess Neoadjuvant Durvalumab (D) and Platinum-Based Chemotherapy (CT), Followed by Either Surgery and Adjuvant D or CRT and Consolidation D, in ResectNon-small Cell Lung Canceractive not recruiting142
2026-01-12P2Pfizer PFENCT06105632 A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic BrAdvanced or Metastatic Breast Canceractive not recruiting333
2026-01-12 est.P2EMD Serono Research & Development Institute, Inc.NCT06424717 Study of Avelumab and Tuvusertib in Participants With Advanced Urothelial Cancer That Has Progressed on Prior Anti-PD-(L)1 Therapy (JAVELIN DDRiver Bladder)Urothelial Carcinomawithdrawn
2026-01-12P3argenx ARGXNCT06558279 A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC in Adults With Ocular Myasthenia GravisMyasthenia Gravis, Ocularactive not recruiting141
2026-01-12P2Eli Lilly and Company LLYNCT06568042 Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory PolyneuropathyNeuropathic Pain; Distal Sensory Polyneuropathycompleted558
2026-01-12P2Thiogenesis Therapeutics, Inc. TTIPFNCT06644534 A Study to Assess TTI-0102 vs Placebo in MELAS PatientsMELAS Syndrome; Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-like Episodes (MELAS)completed9
2026-01-12P2Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure TherapeuticsNCT06703021 A Dose-Range Study of Aleniglipron (GSBR-1290) in Participants Living With Obesity or Overweight With at Least One Weight-related ComorbidityObesity; Overweight; Chronic Weight Managementcompleted85
2026-01-12P2Kardigan, Inc. KARDNCT06864104 A Study to Investigate Tonlamarsen for the Treatment of Adults With Uncontrolled Hypertension (KARDINAL)Hypertensioncompleted206
2026-01-12P3Sanofi SNYNCT07079670 Safety and Immunogenicity of NVX-CoV2705COVID-19; SARS-CoV-2 Infectioncompleted676
2026-01-13P1/P2Taiho Oncology, Inc.NCT03502668 Phase 1-2 Study of Low Dose ASTX727 (ASTX727 LD) in Lower Risk MDSMyelodysplastic Syndromescompleted160
2026-01-13P3OctapharmaNCT04867837 Study of OCTAPLEX in Patients With Acute Major Bleeding on DOAC Therapy With Factor Xa InhibitorAcute Major Bleedingterminated100
2026-01-13P2Barinthus BiotherapeuticsNCT05343481 Efficacy of VTP-300 in Chronic Hepatitis B InfectionChronic Hepatitis Bcompleted121
2026-01-13P3Sichuan Baili Pharmaceutical Co., Ltd.NCT06382142 A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer(PATriple-Negative Breast Canceractive not recruiting418
2026-01-13P1/P2GlaxoSmithKlineNCT06382311 A Study to Find and Confirm the Dose and Assess Safety, Reactogenicity and Immune Response of a Vaccine Against Pandemic H5N1 Influenza Virus in Healthy YoungerInfluenza, Humancompleted991
2026-01-13P2Boehringer IngelheimNCT06675929 A Study to Test How Well BI 770371 is Tolerated by People With Cirrhosis Caused by a Liver Disease Called MASHCompensated Liver Cirrhosis; Metabolic Dysfunction Associated Steatohepatitis (MASH)completed28
2026-01-14P3Merck Sharp & Dohme LLC MRKNCT02684292 Study of Pembrolizumab (MK-3475) vs. Brentuximab Vedotin in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (MK-3475-204/KEYNOTE-204)Hodgkin Lymphomacompleted304
2026-01-14P2GlaxoSmithKlineNCT04494412 An Intravenous (IV) Zanamivir Pharmacokinetics (PK) Study in Hospitalized Neonates and Infants With Influenza InfectionInfluenza, Human; Arthralgiacompleted8
2026-01-14P3Eli Lilly and Company LLYNCT05559359 A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic DermatitisAtopic Dermatitis; Eczemaactive not recruiting377
2026-01-14P3Palvella Therapeutics, Inc. PVLANCT06239480 SELVA: A Phase 3 Study Evaluating QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Microcystic Lymphatic MalformationsMicrocystic Lymphatic Malformationactive not recruiting51
2026-01-14P3Shanghai Hutchison Pharmaceuticals LimitedNCT06377072 Efficacy and Safety of Shenqi Sherong Pill in Participants With Cervical Spondylotic MyelopathyCervical Spondylotic Myelopathycompleted428
2026-01-14P2BioTheraVision, Inc.NCT06543303 Evaluation of BTV100 in Subjects With Dry Eye DiseaseDry Eyecompleted123
2026-01-14P2Kissei Pharmaceutical Co., Ltd.NCT06722729 A Late Phase II Clinical Trial of KDT-3594 in Patients With Parkinson's DiseaseParkinson Diseasecompleted178
2026-01-14P2BrightGene Bio-Medical Technology Co., Ltd.NCT06911203 A Study of BGM0504 in Participants With ObesityObesitycompleted96
2026-01-15P2CelgeneNCT03601078 An Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma and in Subjects With High-Risk Multiple MyelomaMultiple Myelomacompleted312
2026-01-15 est.P2/P3Laminar PharmaceuticalsNCT04250922 LAM561 With RT and TMZ for Adults With GlioblastomaPrimary Glioblastoma; Glioblastoma Multiformeactive not recruiting144
2026-01-15P3Orchard TherapeuticsNCT04283227 OTL-200 in Patients With Late Juvenile Metachromatic Leukodystrophy (MLD)Lysosomal Storage Diseases; Metachromatic Leukodystrophyactive not recruiting6
2026-01-15P3Immedica Pharma ABNCT05299554 Long-term Safety Study of Chronocort in the Treatment of Participants With Congenital Adrenal HyperplasiaCongenital Adrenal Hyperplasiacompleted76
2026-01-15P1/P2TCRCure Biopharma Ltd.NCT05357027 HPV16 E6 TCR T Cells for Cervical CarcinomaCervical Carcinomaterminated5
2026-01-15P3Hangzhou Highlightll Pharmaceutical Co., LtdNCT06020144 A Phase 3 Study Comparing TLL-018 to Tofacitinib in RA Subjects With Inadequate Response or Intolerance to bDMARDsRheumatoid Arthritiscompleted459
2026-01-15P3KalVista Pharmaceuticals, Ltd.NCT06467084 Open-Label Safety, PK, and Efficacy Trial of Sebetralstat (KVD900) in Pediatric Patients (Ages 2-11) With HAE Type I or IIHereditary Angioedemacompleted36
2026-01-15P3Qilu Pharmaceutical Co., Ltd.NCT06837896 Efficacy and Safety Study of QLG1080 in Patients With Hormone-sensitive Advanced Prostate CancerProstate Cancercompleted111
2026-01-15 est.P2Sinovac Biotech Co., Ltd SVANCT07055880 Immunogenicity and Safety of Different Dosages of Rabies Vaccine (Serum-free Vero Cell)Rabiesnot yet recruiting120
2026-01-15P3Yuhan CorporationNCT07111468 Clinical Trial to Evaluate the Efficacy and Safety of YHP2401 Compared to YHR2402 and YHR2403 for Acute BronchitisAcute Bronchitiscompleted286
2026-01-16P2/P3Bristol-Myers Squibb BMYNCT03723655 A Long-Term Safety Extension Study of Mavacamten in Adults Who Have Completed MAVERICK-HCM or EXPLORER-HCMHypertrophic Cardiomyopathy; Obstructive Hypertrophic Cardiomyopathy; Non-obstructive Hypertrophic Ccompleted314
2026-01-16P3Mirati Therapeutics Inc.NCT04793958 Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10)Advanced Colorectal Cancer; Metastatic Colorectal Canceractive not recruiting461
2026-01-16P3Dizal PharmaceuticalsNCT05668988 A Study of DZD9008 Versus Platinum-Based Doublet Chemotherapy in Local Advanced or Metastatic Non-small Cell Lung Cancer (WU-KONG28)Non-small Cell Lung Canceractive not recruiting324
2026-01-16 est.P2Loxo Oncology, Inc.NCT06104683 A Study of Pirtobrutinib (LY3527727 [LOXO-305]) Versus Placebo in Participants With Relapsing Multiple SclerosisRelapsing Multiple Sclerosis; Multiple Sclerosiswithdrawn
2026-01-16P2H. Lundbeck A/SNCT06323928 A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive TreatmentsMigrainecompleted874
2026-01-16P2Eli Lilly and Company LLYNCT06643728 A Study to Investigate Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Adults With Obesity or OverweightObesity; Overweightcompleted252
2026-01-16P3Lipocine Inc. LPCNNCT06979544 A Study to Assess the Safety and Efficacy of Oral LPCN 1154A in Women With Severe PPDDepression, Postpartum; Depression, Post-Partum; Postpartum Depression (PPD); Post-Natal Depression;completed90
2026-01-16P3Nanjing Zenshine PharmaceuticalsNCT07095257 Study to Assess the Safety and Efficacy of ZX-7101A for Oral Suspension in Chinese Pediatric Participants 2 to 11 Years of Age With InfluenzaRespiratory Viral Infectioncompleted169
2026-01-17P3Guangdong Raynovent Biotech Co., LtdNCT07229807 Efficacy and Safety of ZSP1273 in Children 2-11 Years Old With Influenza AInfluenza acompleted120
2026-01-19P2ModernaTX, Inc.NCT04975893 A Long-Term Extension Study to Evaluate the Immunogenicity and Safety of Cytomegalovirus (CMV) mRNA-1647 VaccineCytomegalovirus Infectioncompleted135
2026-01-19P3AstraZeneca AZNNCT05158387 Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations.Chronic Obstructive Pulmonary Disease (COPD)completed1172
2026-01-19P3AstraZeneca AZNNCT05166889 Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of ExacerbationsChronic Obstructive Pulmonary Disease (COPD)completed1132
2026-01-19 est.P2Mankind Pharma LimitedNCT07098663 Food Effect, Efficacy and Safety of MKP10241 in Healthy and Obese Adult Participants, With and Without DiabetesType 2 Diabetes Mellitus (T2DM); Food Effect; Safety and Tolerability; Obesityrecruiting68
2026-01-20P3IBSA Institut Biochimique SANCT04549116 Subcutaneous Progesterone in Frozen- Thawed Single Euploid Blastocyst Transfer.Infertilitycompleted688
2026-01-20P3AVEO Pharmaceuticals, Inc.NCT04987203 Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell CarcinomaRenal Cell Carcinomacompleted343
2026-01-20P2/P3Takeda TAKNCT05755035 A Study About How TAK-881 is Processed by the Body and Side Effects in People With Primary Immunodeficiency DiseasesPrimary Immunodeficiency Diseases (PID)completed65
2026-01-20P3Eli Lilly and Company LLYNCT06047548 A Study of LY3298176 (Tirzepatide) For the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related ComorbiditiesOverweight; Obesitycompleted441
2026-01-20 est.P2Xizang Haisco Pharmaceutical Co., LtdNCT06996912 A Study for HSK44459 in Participants With Atopic DermatitisAtopic Dermatitis (AD)active not recruiting150
2026-01-20P3Sanofi SNYNCT07002060 Phase 3 Randomized, Modified Double-blind, Active-controlled Safety Study on vYF in AdultsYellow Fever Immunizationcompleted640
2026-01-20P2EMSNCT07843056 A Clinical Trial to Compare the Efficacy and Safety of WAS123 Versus Daily Aripiprazole in the Maintenance Treatment of Patients With Schizophrenia.Schizophenia Disordercompleted121
2026-01-21P3Merck Sharp & Dohme LLC MRKNCT04210115 Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNEsophageal Squamous Cell Carcinoma (ESCC); Gastroesophageal Junction Carcinoma (GEJC); Esophageal Adcompleted703
2026-01-21P2AfimmuneNCT05861453 Pharmacokinetics, Pharmacodynamics and Safety of Epeleuton in Patients With Sickle Cell DiseaseSickle Cell Diseasecompleted35
2026-01-21P2Guangdong Hengrui Pharmaceutical Co., LtdNCT05891483 Efficacy and Safety of SHR-1905 Injection in Patients With Chronic Rhinosinusitis With Nasal PolypsChronic Rhinosinusitis With Nasal Polypscompleted114
2026-01-21P3Dongkook Pharmaceutical Co., Ltd.NCT06490328 Efficacy and Safety of DKF-MA102 in Patients With Prostate CancerAdvanced Prostate Cancercompleted161
2026-01-21P2Indivior Inc.NCT06576843 INDV-6001 Multiple-Dose Pharmacokinetic StudyModerate to Severe Opioid Use Disordercompleted123
2026-01-21P3Sun Pharmaceutical Industries LimitedNCT06611163 A Study to Evaluate the Efficacy and Safety of Subcutaneous Tildrakizumab in Subjects With Moderate to Severe Genital Psoriasis.Moderate to Severe Genital Psoriasisactive not recruiting206
2026-01-21P3Fujian Shengdi Pharmaceutical Co., Ltd.NCT06650007 the Efficacy and Safety of HRS9531 Injection in Subjects With Type 2 Diabetes, Inadequately Controlled With Diet and Exercise AloneDiabetes Mellitus, Type 2completed218
2026-01-21P2Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.NCT06978699 A Phase II Study Evaluating the Efficacy and Safety of XH-S003 Capsules in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)PNH - Paroxysmal Nocturnal Hemoglobinuriacompleted26
2026-01-22P3AstraZeneca AZNNCT06067828 A Study to Evaluate the Effect of Budesonide, Glycopyrronium, Formoterol Fumarate (BGF) Metered Dose Inhaler (MDI), Budesonide and Formoterol Fumarate (BFF) MDIChronic Obstructive Pulmonary Diseasecompleted171
2026-01-22P3Eli Lilly and Company LLYNCT06354660 Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (TRANSCEND-TDiabetes Type 2completed537
2026-01-22P2InflaRx GmbH IFRXNCT06555328 Evaluate Safety and Pharmacokinetics of INF904 in Subjects With Moderate to Severe Chronic Spontaneous Urticaria or Hidradenitis SuppurativaChronic Urticaria, Idiopathic; Hidradenitis; Hidradenitis Suppurativaterminated73
2026-01-23P3Seagen, a wholly owned subsidiary of PfizerNCT04404283 Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCLDiffuse Large B-cell Lymphomaactive not recruiting240
2026-01-23P3ViiV HealthcareNCT05911360 A Study to Evaluate Efficacy, Safety and Tolerability in Antiretroviral Therapy (ART)-Experienced Participants of at Least 50 Years of Age Living With Human ImmHIV; HIV Infectionscompleted205
2026-01-23P3CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.NCT06258148 A Study of TG103 Injection Monotherapy in Treatment of Type 2 Diabetes MellitusType 2 Diabetes Mellituscompleted465
2026-01-23P3SandozNCT06587451 Integrated Pharmacokinetics (PK)/Efficacy, Safety, and Immunogenicity Study to Demonstrate Similarity of JPB898, a Proposed Biosimilar to Nivolumab, to Opdivo® Melanomaterminated52
2026-01-23P2Prelude Therapeutics Incorporated PRLDNCT06682806 A Study of PRT3789 in Combination With Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 MutationAdvanced Solid Tumor; Esophageal Cancer; Metastatic Solid Tumor; Non-small Cell Lung Cancers; SMARCAterminated6
2026-01-23P1/P2Genenta Science SAENNCT06716853 A Clinical Gene Therapy Study With Hematopoietic Stem Cells for the Treatment, With Single Dose of Temferon, of Patients Suffering From Metastatic Renal Cell CaClear Cell RCCterminated10
2026-01-23P2Halia Therapeutics, Inc.NCT07172867 A Ph2 Study to Evaluate the Safety, Efficacy and Tolerability of HT-6184 and Semaglutide in Obese Participants With T2DMDiabetes Mellitus, Type 2; Obesitywithdrawn
2026-01-25 est.P1/P2Innolake BiopharmNCT05955105 A Study of ILB2109 and Toripalimab in Patients With Advanced Solid MalignanciesHead and Neck Cancer; Cervical Cancer; Endometrial Cancer; Triple Negative Breast Cancer; Ovarian Caunknown200
2026-01-26P3Merck Sharp & Dohme LLC MRKNCT03924856 Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invBladder Cancercompleted907
2026-01-26P2AbbVie ABBVNCT04295538 Safety And Efficacy Study Of Intravenous (IV) Administration Of Elezanumab To Assess Change In Upper Extremity Motor Score (UEMS) In Adult Participants With AcuSpinal Cord Injury (SCI)completed60
2026-01-26P2OncoSil Medical LimitedNCT05466799 FOLFIRINOX Versus OncoSil™ in Addition to FOLFIRINOX in Patients With Locally Advanced Pancreatic AdenocarcinomaLocally Advanced Pancreatic Canceractive not recruiting88
2026-01-26P3Cassiopea SpANCT05910450 A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair LossAlopecia, Androgeneticcompleted703
2026-01-26P2Shanghai SIMR Biotechnology Co., Ltd.NCT06571448 Efficacy, Safety, and Tolerability of SR750 in Patients With Trigeminal NeuralgiaTrigeminal Neuralgiacompleted138
2026-01-26P3Livzon Pharmaceutical Group Inc.NCT07746479 A Study to Evaluate the Efficacy and Safety of LZM012 ( Psoriasis )Psoriasiscompleted244
2026-01-27P3Hoffmann-La RocheNCT04586010 A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)Relapsing Multiple Sclerosisactive not recruiting746
2026-01-27P2Ono Pharmaceutical Co., Ltd.NCT04947319 Study of Tirabrutinib (ONO-4059) in Patients With Primary Central Nervous System Lymphoma (PROSPECT Study)Refractory Primary Central Nervous System Lymphoma; Primary CNS Lymphomaactive not recruiting119
2026-01-27 est.P1/P2Tallac TherapeuticsNCT05399654 A Dose Escalation and Expansion Study of TAC-001 in Patients With Select Advanced or Metastatic Solid TumorsAdvanced or Metastatic Solid Tumorsunknown72
2026-01-28P1/P2Merck Sharp & Dohme LLC MRKNCT03598608 Study to Evaluate the Safety and Efficacy of a Combination of Favezelimab (MK-4280) and Pembrolizumab (MK-3475) in Participants With Hematologic Malignancies (MHodgkin Disease; Lymphoma, Non-Hodgkin; Lymphoma, B-Cellterminated137
2026-01-28P1/P2Amgen AMGNNCT05325866 A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) OverexpressionSolid Tumorsterminated260
2026-01-28 est.P3AkesoNCT05489289 A Phase III Study of AK104 as Adjuvant Therapy in HCC With High Risk of Recurrence After Curative ResectionHepatocellular Carcinomarecruiting570
2026-01-28P3Novartis Pharmaceuticals NVSNCT06869785 Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of OfatumumabRelapsing Multiple Sclerosis (RMS)active not recruiting196
2026-01-28P2Graviton Bioscience CorporationNCT06979505 GV101 in Healthy Obese ParticipantsWeight Managementcompleted131
2026-01-28P1/P2AstraZeneca AZNNCT07128615 A Phase I/II Study on Safety AND Immunogenicity of AZD4117 and AZD5315 Vaccines (PANDA)Influenza Aactive not recruiting405
2026-01-28P3Colgate Palmolive CLNCT07224828 The Efficacy of a Battery Toothbrush in the Reduction of Established Plaque and GingivitisPlaque; Gingivitiscompleted130
2026-01-29P3Mundipharma Research LimitedNCT04368559 Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow TransCandidemia; Mycoses; Fungal Infection; Fungemia; Invasive Candidiasis; Pneumocystis; Mold Infection;completed602
2026-01-29P3Vertex Pharmaceuticals Incorporated VERXNCT05153317 Evaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA in Cystic Fibrosis (CF) Participants 2 Years and OlderCystic Fibrosiscompleted71
2026-01-29P3Inozyme PharmaNCT06046820 The ENERGY 3 Study: Evaluation of Efficacy and Safety of INZ-701 in Children With ENPP1 DeficiencyEctonucleotide Pyrophosphatase/Phosphodiesterase1 Deficiency; Autosomal Recessive Hypophosphatemic Rterminated27
2026-01-29P3Taizhou Mabtech Pharmaceutical Co.,LtdNCT06365879 To Compare Efficacy and Safety of CMAB007 and Xolair® in Patients With Chronic Spontaneous UrticariaChronic Spontaneous Urticariacompleted392
2026-01-29P2Sanofi SNYNCT06454240 A Proof-of-concept Study of Lunsekimig Compared With Placebo in Adults With Chronic Rhinosinusitis With Nasal PolypsChronic Rhinosinusitis With Nasal Polypscompleted79
2026-01-29P3Jiangsu HengRui Medicine Co., Ltd.NCT06596876 A Study to Evaluate the Efficacy and Safety of HRG2010 in Parkinson's Disease With Motor FluctuationsParkinson's Diseasecompleted165
2026-01-29P2RDC Clinical Pty LtdNCT06907680 M-Gard Particulate EW Efficacy Study on Seasonal Allergic RhinitisAllergic Rhinitis Due to Grass Pollenscompleted20
2026-01-30P3Hoffmann-La RocheNCT04546009 A Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Participants With EstrEstrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Canceractive not recruiting992
2026-01-30P1/P2COUR Pharmaceutical Development Company, Inc.NCT05104853 Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects With Primary Biliary CholangitisPrimary Biliary Cholangitiscompleted42
2026-01-30P2AkesoNCT05215067 A Phase II Trial of AK104 in Advanced Non-Small Cell Lung CancerAdvanced Non-small Cell Lung Cancercompleted44
2026-01-30P1/P2Nanjing Leads Biolabs Co.,LtdNCT05516914 A Phase Ib/II Clinical Trial of LBL-007 Combined With Tislelizumab in the Treatment of Malignant TumorsMalignant Tumorscompleted98
2026-01-30 est.P3Genor Biopharma Co., Ltd.NCT05851014 A Study of GB491 in Combination With Letrozole in Patients With HR Positive and HER2 Negative Advanced Breast CancerBreast Cancerrecruiting350
2026-01-30P3PolarityTENCT06140303 SkinTE® for the Treatment of Wagner 1 Diabetic Foot Ulcers (COVER DFUS II)Diabetic Footcompleted120
2026-01-30P2Shanghai Hengrui Pharmaceutical Co., Ltd.NCT06199037 Safety and Pharmacodynamics of SHR-1707 in Alzheimer's Disease PatientsAlzheimer's Diseaseterminated46
2026-01-30 est.P2Shanghai Runshi Pharmaceutical Technology Co., LtdNCT06512428 A Study of Simmitinib Plus Irinotecan in Advanced Esophageal Squamous Cell CarcinomaAdvanced Esophageal Squamous Cell Carcinomaunknown138
2026-01-30P1/P2Corbus Pharmaceuticals Inc. CRBPNCT06603844 First-in-human Study of CRB-601-01 to Treat Patients With Advanced Solid Tumor.Solid Tumorcompleted51
2026-01-30 est.P1/P2DexTech Medical ABNCT06616389 Study of ODX (OsteoDex) in Multiple MyelomaMultiple Myelomarecruiting12
2026-01-30P3Quince Therapeutics S.p.A.NCT06664853 Open-Label Extension of EryDex Study IEDAT-04-2022Ataxia Telangiectasiaterminated101
2026-01-30 est.P1/P2Tr1X, Inc.NCT06721962 Treatment of Moderate to Severe Refractory Crohn's DiseaseCrohns Diseaserecruiting39
2026-01-30P2BioTissue Holdings, IncNCT06780306 A Study in the Treatment of Mild to Moderate Dry Eye Disease Comparing Saline to TTAX03.Dry Eye; Dry Eye Disease (DED); Dry Eye Disease With Severe Keratitiscompleted74
2026-01-30 est.P1/P2Shanghai Huaota Biopharmaceutical Co., Ltd.NCT06895499 Efficacy, Safety, and Tolerability of HB0043 in Hidradenitis Suppurativa Patients.Hidradenitis Suppurativarecruiting15
2026-01-31P3Suzhou Zelgen Biopharmaceuticals Co.,LtdNCT04964284 rhTSH for Radioactive Iodine Remnant Ablation in Participants With Differentiated Thyroid Cancer (DTC)Differentiated Thyroid Cancercompleted390
2026-01-31P2GlaxoSmithKlineNCT05583344 Phase 2b Study of GSK4532990 in Adults With NASHNonalcoholic Fatty Liver Disease; Non-alcoholic Fatty Liver Diseasecompleted284
2026-01-31 est.P1/P2Minghui Pharmaceutical Pty LtdNCT05652855 Study of MHB088C in Participants With Advanced or Metastatic Solid TumorsAdvanced or Metastatic Solid Tumorsunknown48
2026-01-31 est.P3Sound Wave Innovation CO., LTD. SOGPNCT05983575 A Pivotal Study of LIPUS-Brain in Patients With Early Alzheimer's DiseaseAlzheimer Disease, Early Onsetactive not recruiting220
2026-01-31P2Biologische Heilmittel Heel GmbHNCT06278077 Neurexan - a Clinical Trial in Short-Term Insomnia PatientsInsomnia; Stress Reactioncompleted81
2026-01-31 est.P1/P2Hinova Pharmaceuticals Inc.NCT06757335 A Phase I/II Trial to Evaluate Oral HP568 Tablets in Patients with ER+/HER2 Advanced Breast CancerBreast Cancernot yet recruiting204
2026-01-31 est.P2Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT07109700 A Study of HDM1005 in Participants With T2DM Not Controlled With Diet/Exercise or MetforminType 2 Diabetesrecruiting216
2026-01-31 est.P3Tatchempharmpreparaty, JSCNCT07167550 The Study of Efficacy and Safety of Dimephosphon® in Acute Ischemic StrokeStroke; Acute Stroke; Ischemic Stroke; Cerebrovascular Disorders; Physiological Effects of Drugsrecruiting184
2026-01-31 est.P3Joincare Pharmaceutical Group Industry Co., LtdNCT07357051 Phase III Clinical Study Evaluating the Safety, Pharmacokinetics, and Efficacy of JKN2301 Dry Suspension in Pediatric Patients Aged 2 to Under 12 Years With InfRespiratory Viral Infectionrecruiting177

← 2025-12 | 2026-02 →

Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA (openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score. Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP readout_calendar / fda_decisions. Not investment advice.